ID EFNB3_HUMAN Reviewed; 340 AA. AC Q15768; O00680; Q8TBH7; Q92875; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 07-JUL-2009, entry version 86. DE RecName: Full=Ephrin-B3; DE AltName: Full=EPH-related receptor tyrosine kinase ligand 8; DE Short=LERK-8; DE AltName: Full=EPH-related receptor transmembrane ligand ELK-L3; DE Flags: Precursor; GN Name=EFNB3; Synonyms=EPLG8, LERK8; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Cerretti D.P.; RL Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Brain; RX MEDLINE=97271551; PubMed=9126477; DOI=10.1006/geno.1997.4615; RA Tang X.X., Pleasure D.E., Ikegaki N.; RT "cDNA cloning, chromosomal localization, and expression pattern of RT EPLG8, a new member of the EPLG gene family encoding ligands of EPH- RT related protein-tyrosine kinase receptors."; RL Genomics 41:17-24(1997). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Brain cortex; RX MEDLINE=96404527; PubMed=8808709; RA Gale N.W., Flenniken A., Compton D.C., Jenkins N.A., Copeland N.G., RA Gilbert D.J., Davis S., Wilkinson D.G., Yancopoulos G.D.; RT "Elk-L3, a novel transmembrane ligand for the Eph family of receptor RT tyrosine kinases, expressed in embryonic floor plate, roof plate and RT hindbrain segments."; RL Oncogene 13:1343-1352(1996). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP PROTEIN SEQUENCE OF 28-42. RX PubMed=15340161; DOI=10.1110/ps.04682504; RA Zhang Z., Henzel W.J.; RT "Signal peptide prediction based on analysis of experimentally RT verified cleavage sites."; RL Protein Sci. 13:2819-2824(2004). RN [6] RP INTERACTION WITH GRIP1 AND GRIP2. RC TISSUE=Fetal brain; RX MEDLINE=99211388; PubMed=10197531; DOI=10.1016/S0896-6273(00)80706-0; RA Brueckner K., Pablo Labrador J., Scheiffele P., Herb A., Seeburg P.H., RA Klein R.; RT "EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft RT membrane microdomains."; RL Neuron 22:511-524(1999). RN [7] RP INTERACTION WITH NIPAH VIRUS PROTEIN G, AND MUTAGENESIS OF RP 124-LEU-TRP-125. RX PubMed=16477309; DOI=10.1371/journal.ppat.0020007; RA Negrete O.A., Wolf M.C., Aguilar H.C., Enterlein S., Wang W., RA Muehlberger E., Su S.V., Bertolotti-Ciarlet A., Flick R., Lee B.; RT "Two key residues in ephrinB3 are critical for its use as an RT alternative receptor for Nipah virus."; RL PLoS Pathog. 2:78-86(2006). CC -!- FUNCTION: May play a pivotal role in forebrain function. Binds to, CC and induce the collapse of, commissural axons/growth cones in CC vitro. May play a role in constraining the orientation of CC longitudinally projecting axons (By similarity). CC -!- SUBUNIT: Interacts with GRIP1 and GRIP2. Binds to Nipah virus G CC protein. CC -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane CC protein. CC -!- TISSUE SPECIFICITY: Highly expressed in brain; expressed in CC embryonic floor plate, roof plate and hindbrain segments. CC -!- SIMILARITY: Belongs to the ephrin family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; U57001; AAB05170.1; -; mRNA. DR EMBL; U66406; AAC51203.1; -; mRNA. DR EMBL; U62775; AAC50707.1; -; mRNA. DR EMBL; BC022499; AAH22499.1; -; mRNA. DR EMBL; BC042944; AAH42944.1; -; mRNA. DR IPI; IPI00019501; -. DR RefSeq; NP_001397.1; -. DR UniGene; Hs.26988; -. DR HSSP; P52800; 1IKO. DR PhosphoSite; Q15768; -. DR PRIDE; Q15768; -. DR Ensembl; ENSG00000108947; Homo sapiens. DR GeneID; 1949; -. DR KEGG; hsa:1949; -. DR UCSC; uc002gis.1; human. DR GeneCards; GC17P007549; -. DR H-InvDB; HIX0021522; -. DR HGNC; HGNC:3228; EFNB3. DR HPA; HPA001623; -. DR MIM; 602297; gene. DR PharmGKB; PA27663; -. DR HOGENOM; Q15768; -. DR HOVERGEN; Q15768; -. DR OMA; Q15768; MGAPHSG. DR Pathway_Interaction_DB; ephbfwdpathway; EPHB forward signaling. DR NextBio; 7899; -. DR PMAP-CutDB; Q15768; -. DR ArrayExpress; Q15768; -. DR Bgee; Q15768; -. DR CleanEx; HS_EFNB3; -. DR GermOnline; ENSG00000108947; Homo sapiens. DR GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc. DR GO; GO:0046875; F:ephrin receptor binding; IDA:MGI. DR GO; GO:0005005; F:transmembrane-ephrin receptor activity; TAS:ProtInc. DR GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc. DR GO; GO:0048013; P:ephrin receptor signaling pathway; IDA:MGI. DR GO; GO:0044419; P:interspecies interaction between organisms; IEA:UniProtKB-KW. DR InterPro; IPR008972; Cupredoxin. DR InterPro; IPR001799; Ephrin. DR InterPro; IPR019765; Ephrin_CS. DR Gene3D; G3DSA:2.60.40.420; Cupredoxin; 1. DR PANTHER; PTHR11304; Ephrin; 1. DR Pfam; PF00812; Ephrin; 1. DR PRINTS; PR01347; EPHRIN. DR ProDom; PD002533; Ephrin; 1. DR PROSITE; PS01299; EPHRIN; 1. PE 1: Evidence at protein level; KW Complete proteome; Developmental protein; Differentiation; KW Direct protein sequencing; Disulfide bond; Glycoprotein; KW Host-virus interaction; Membrane; Neurogenesis; Polymorphism; Signal; KW Transmembrane. FT SIGNAL 1 27 FT CHAIN 28 340 Ephrin-B3. FT /FTId=PRO_0000008395. FT TOPO_DOM 28 226 Extracellular (Potential). FT TRANSMEM 227 247 Potential. FT TOPO_DOM 248 340 Cytoplasmic (Potential). FT MOTIF 338 340 PDZ-binding (Potential). FT CARBOHYD 210 210 N-linked (GlcNAc...) (Potential). FT DISULFID 62 104 By similarity. FT DISULFID 92 156 By similarity. FT VARIANT 166 166 R -> Q. FT /FTId=VAR_002356. FT MUTAGEN 124 125 LW->YM: Complete loss of Nipah protein G FT binding. SQ SEQUENCE 340 AA; 35835 MW; EDFF2A23C2FDE79F CRC64; MGPPHSGPGG VRVGALLLLG VLGLVSGLSL EPVYWNSANK RFQAEGGYVL YPQIGDRLDL LCPRARPPGP HSSPNYEFYK LYLVGGAQGR RCEAPPAPNL LLTCDRPDLD LRFTIKFQEY SPNLWGHEFR SHHDYYIIAT SDGTREGLES LQGGVCLTRG MKVLLRVGQS PRGGAVPRKP VSEMPMERDR GAAHSLEPGK ENLPGDPTSN ATSRGAEGPL PPPSMPAVAG AAGGLALLLL GVAGAGGAMC WRRRRAKPSE SRHPGPGSFG RGGSLGLGGG GGMGPREAEP GELGIALRGG GAADPPFCPH YEKVSGDYGH PVYIVQDGPP QSPPNIYYKV //